Gerber Lynn H, Hoffman Karen, Chaudhry Usha, Augustine Elizabeth, Parks Rebecca, Bernad Martha, Mackall Crystal, Steinberg Seth, Mansky Patrick
Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA. ngerber1@gmu
Arch Phys Med Rehabil. 2006 Dec;87(12):1611-7. doi: 10.1016/j.apmr.2006.08.341.
To describe the inter-relationships among impairments, performance, and disabilities in survivors of pediatric sarcoma and to identify measurements that profile survivors at risk for functional loss.
Prospective, cross-sectional.
Research facility.
Thirty-two participants in National Cancer Institute clinical trials.
Not applicable.
Range of motion (ROM), strength, limb volume, grip strength, walk velocity, Assessment of Motor and Process Skills (AMPS); Human Activity Profile (HAP), Sickness Impact Profile (SIP), standard form of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36); and vocational attitudes and leisure satisfaction.
Twenty of 30 survivors tested had moderate or severe loss of ROM; 13 of 31 tested had 90% or less of predicted walk velocity; all of whom had trunk or lower-extremity lesions. Women with decreased ROM (r=.50, P=.06) or strength (r=.74, P=.002) had slow gait velocity. Sixteen of 31 tested were more than 1 standard deviation below normal grip strength. Eighteen had increased limb volume. These 18 had low physical competence (SF-36) (r=-.70, P=.001) and high SIP scores (r=.73, P=.005). AMPS scores were lower than those of the matched normed sample (P<.001). HAP identified 15 of 30 who had moderately or severely reduced activity. Leisure satisfaction was higher in the subjects (P<.001). Eight reported cancer had negatively impacted work and 17 reported that it negatively impacted vocational plans.
Survivors with lower-extremity or truncal lesions and women with decreased ROM and strength likely have slow walk velocity, low exercise tolerance, and high risk for functional loss. They should be identified using ROM, strength, limb volume, and walk time measures.
描述小儿肉瘤幸存者损伤、功能表现和残疾之间的相互关系,并确定能够识别有功能丧失风险幸存者的测量指标。
前瞻性横断面研究。
研究机构。
32名参与美国国立癌症研究所临床试验的受试者。
不适用。
关节活动范围(ROM)、力量、肢体体积、握力、步行速度、运动与过程技能评估(AMPS);人类活动概况(HAP)、疾病影响概况(SIP)、医学结局研究36项简短健康调查(SF-36)的标准形式;以及职业态度和休闲满意度。
30名接受测试的幸存者中有20名存在中度或重度ROM丧失;31名接受测试者中有13名步行速度低于预测速度的90%;他们均有躯干或下肢病变。ROM降低(r = 0.50,P = 0.06)或力量降低(r = 0.74,P = 0.002)的女性步态速度较慢。31名接受测试者中有16名握力低于正常水平1个标准差以上。18名肢体体积增大。这18名受试者身体能力较低(SF-36)(r = -0.70,P = 0.001)且SIP评分较高(r = 0.73,P = 0.005)。AMPS评分低于匹配的常模样本(P < 0.001)。HAP识别出30名中有15名活动中度或重度减少。受试者的休闲满意度较高(P < 0.001)。8名报告癌症对工作有负面影响,17名报告癌症对职业规划有负面影响。
下肢或躯干病变的幸存者以及ROM和力量降低的女性可能步态速度较慢、运动耐量低且功能丧失风险高。应使用ROM、力量、肢体体积和步行时间测量指标来识别他们。